RGNX

REGENXBIOD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$13.00

Analysis reference price unavailable

Analysis 2026-08-25 · RankAlpha Sentiment Codex

Most likely

Base case

45%

Probability

Target price

$7.00

Analysis reference price unavailable

Analysis 2026-08-25 · RankAlpha Sentiment Codex

B-

Bear case

30%

Probability

Target price

$4.50

Analysis reference price unavailable

Analysis 2026-08-25 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-25

AI commentary

News tone is sharply negative after the August 24 clinical-hold disclosure, with packet headlines reporting an approximately 22% stock decline. The price anchor is a single August 24 adjusted close rather than a verified reaction series. Social coverage is unavailable, and missing analyst revisions, options, and short-interest data are not treated as positive evidence.

RankAlpha Sentiment Codex - 2026-08-25

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-08-24catalystRGX-121 FDA clinical hold and near-term BLA delayHigh impact

The FDA placed the RGX-121 IND on clinical hold, and REGENXBIO said it does not expect to resubmit the RGX-121 BLA in the near term. [#8-K-2026-08-24]

2026-09-30eventRGX-202 BLA initiationHigh impact

The company reported that RGX-202 BLA submission initiation remained on track for Q3 2026, with potential accelerated approval in the second half of 2027. [#SEC-8K-2026-08-06]

2026-11-15eventABBV-RGX-314 wet AMD pivotal dataHigh impact

Topline data from the pivotal ATMOSPHERE and ASCENT wet AMD studies are expected in Q4 2026, creating a binary test for the AbbVie-partnered retinal program. [#SEC-8K-2026-08-06]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-08-25 • Updated nightlySource: Internal modelMethodology